Search
AbbVie Inc
ABBVAdd to Watchlist
288.240USD
-6.590-2.24%
Close 11-05 16:00（ET）
509.35BMarket Cap
141.84P/E TTM
After-hours 19:54 (ET)287.940USD-0.700-0.24%
After-hours 19:54 (ET)AbbVie Inc (ABBV) Stock Price Target & Forecast
Analyst Rating
Based on 32 analysts giving stock ratings to AbbVie Inc in the past month.
Buy
8 Strong Buy
18 Buy
6 Hold
0 Sell
0 Strong Sell
Target Price
295.002USD+0.04%
ABBV Analyst Recommendation Trends
In the current month, ABBV has received 18 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. ABBV average Analyst price target in the last month is 295.002.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
8
8
7
7
7
6
5
5
18
19
19
19
19
19
18
17
6
6
6
7
8
9
10
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32
33
32
33
34
34
33
33
ABBV Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Regeneron Pharmaceuticals Inc
REGN
6
15
9
0
0
30
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Financial Forecasting
Based on analysts' estimates, ABBV EPS is projected to reach 3.871 in FY2026Q4, following reported EPS of 2.377 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
2.59
3.60
3.75
3.87
3.45
Actual
0.39
2.04
2.38
--
--
Surprise
-85.08%
-43.52%
-36.58%
--
--
FAQs
What is AbbVie Inc's expected revenue for the next quarter?
AbbVie Inc's expected revenue is 18.32B.
What is AbbVie Inc's price target?
Analysts forecast that AbbVie Inc's price target is USD 295.00, with the highest forecast at USD 350.00 and the lowest forecast at USD 197.05.
How have AbbVie IncABBV's recent earnings per share performed?
The market expectation was USD 2.38, while AbbVie IncABBV's earnings per share (EPS) for the previous quarter was USD 2.04. EPS for the next quarter is expected at USD 3.87.
What is the analyst rating for AbbVie Inc?
Based on the ratings of AbbVie Inc's stock from 32 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.